Methods for generating phosphorylation site-specific immunological reagents
AssigneeBrookhaven Science Associates, LLC
InventorsCarl W. Anderson, Ettore Appella, Kazuyasu Sakaguchi
Life of this patent
Estimating the term…
Loading patent…
AssigneeBrookhaven Science Associates, LLC
InventorsCarl W. Anderson, Ettore Appella, Kazuyasu Sakaguchi
Estimating the term…
The present invention provides methods for generating phosphorylation site-specific immunological reagents. More specifically, a phosphopeptide mimetic is incorporated into a polypeptide in place of a phosphorylated amino acid. The polypeptide is used as antigen by standard methods to generate either monoclonal or polyclonal antibodies which cross-react with the naturally phosphorylated polypeptide. The phosphopeptide mimetic preferably contains a non-hydrolyzable linkage from the appropriate carbon atom of the amino acid residue to a phosphate group. A preferred linkage is a CF2 group. Such a linkage is used to generate the phosphoserine mimetic F2Pab, which is incorporated into a polypeptide sequence derived from p53 to produce antibodies which recognize a specific phosphorylation state of p53. A CF2 group linkage is also used to produce the phosphothreonine mimetic F2Pmb, and to produce the phosphotyrosine mimetic, F2Pmp.
A method for isolating polyclonal antibodies which bind specifically to a phosphorylated polypeptide which is phosphorylated at a particular amino acid, comprising:
A method for isolating monoclonal antibodies which bind specifically to a phosphorylated polypeptide which is phosphorylated at a particular amino acid, comprising:
Dependencies are inferred from the claim text.